Yiys.,?i:.:ffii*.

"g;

Date:10/ 02/ 2017

Depury Manaser
uept ofCorpo,itc
Sqr ks
ii?ii:"ffii,i1.J.,:l';,.
forr, MUMBAJ _ 10000j
-
'' T:i'ftll:::;;l,""urts 'or thc quarter and Ninc honrhs cndcd on
R!r obi,8. tion5
..u\ u b _,r. a6?e^n.1
1:j:.ll:15E11_Lt\rin8 a nLr
.'.,.i::':;t;i..,,*--
Ilji.l:-:::" io rub,(r !,te! ib.v! p,car rinl
;;i; : :;;; ili;; ;; ) rl ,f :j jill,
Jrong\irh Ljhird Revjew
'rhisis toryourreco
;;",*
t?"r.,,,.".*;;;";;,iJ
: l*i _lr:
- _ 'rory Audito*olthccohPanv
and rclcrcn.c

I!p)
fq
M Kaly
a^:
DIN 02012180

ls tNorA
Mandrl, Medak oislricl. ls. tNorA.
fr;ftfr it*}#,i*i"dr',rT;'^*}ir*ifr
 Vivo Bio Tech Ltd.
rour urut partner
Oiscove.y

....,,-ii:;i;;;;--jF-=

i vr q;;c
'.fi;;c;

:=5rq-d r;J j

f.r(,.,,ri;c;4;i, ;G;

|.'d...',.dfi*-;;;l'li

;ll;l '":rlfr.--6-ffi
;i'::lii".*-"-.-i'-
ina-'i/i;-iir;q-ri-
lr +'".d-iifu-rn--;6
l.r

r1ltj-'q-iii-fiffi

I.S.INDIA.

3pf'Hit*fd;#t'lffi ii*Tr*:mrtritr,,i$
Mandal, Medak Districl tS. tNolA.
 Vivo Bio Tech [td.
Your Drut Dhcovery parrner

ls.tNDtA.

tqfr #{ffi i,i#iiffl;.,i*dsi"*:'r#"fr ,,,r#

Mandal, iredak oistricl tS. tNotA.
fr
 P. MURAL! & CO Tel. : (91-40) 2332 6666, 2331 2554
CHARTERED ACCOUNTANTS 2339 3967, 2332 1470
Fax : (91-40) 2339 2474
6-3-655/2/3, SOMAJIGUDA,
HYDERABAD - 500 082. INDIA E-mail : pmurali.co@gmail.com
info@pmurali.com
Website : www.pmurali.com

To
The Board of Directors
VIVO BIO TECH LIMITED
Hyderabad.

Limited Review Report for Standalone Financials for the quarter ended 31st December,
2016
1. We have reviewed the accompanying statement of unaudited Standalone financial
results of VIVO BIO TECH Limited
for the quarter ended 31st December, 2016,
being submitted by the Company pursuant to the requirements of Regulation 33 of
the SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015.
2. This statement is the responsibility of the Company's Management and has been
approved by the Board of Directors/ committee of Board of Directors in their
meeting held on 10th February, 2016. Our responsibility is to issue a report on these
financial statements based on our review.
3. We conducted our review in accordance with the Standard on Review Engagement
(SRE) 2410, Review of interim financial information performed by the independent auditor of
the entity issued by the Institute of Chartered Accountants of India. This standard
requires that we plan and perform the review to obtain moderate assurance as to
whether the financial statements are free of material misstatement. A review is
limited primarily to inquiries of company personnel and analytical procedures
applied to financial data and thus provide less assurance than an audit. We have not
performed an audit and accordingly, we do not express an audit opinion.
4. Based on our review conducted as above, nothing has come to our attention that
causes us to believe that the accompanying statement of unaudited financial results
prepared in accordance with applicable accounting standards and other recognized
accounting practices and policies has not disclosed the information required to be
disclosed in terms of Regulation 33 of the SEBI ( Listing obligations and Disclosure
requirements) Regulations, 2015 and SEBI circular dated 05th July 2016 including the
manner in which it is to be disclosed, or that it contains any material misstatement.
For P. Murali & Co.
Chartered Accountants
p,L1 &
FRN: 007257S

A Krishna Rao
Partner
Membership Number.

Place: Hyderabad
Date: 10th February, 2016